• New in the Library
    New in the Library

    New in the Library (April – May 2026)

    Here are the latest items added to the CTN Dissemination Library for April – May 2026 (this post will be updated as new items come in): The community representative council of the National Drug Abuse Treatment Clinical Trials Network: Co-design and early impact [commentary]. Moore SK, et al. Journal of Substance Use & Addiction Treatment 2026 (in press). Experiences of pregnant and postpartum people of color engaged in a randomized clinical trial of medication to treat opioid use disorder during pregnancy: A “Positive Outliers” analysis. Wheeler A, et al. Journal of Substance Use and Addiction Treatment 2026 (in press). (Primary outcomes for CTN-0080-A-2) A scoping review of implementation strategies to reduce stigma toward people who use substances in healthcare settings. Cioffi C, et al. Journal of Substance Use and Addiction Treatment 2026 (in press). Burden of all-cause and cause-specific mortality among individuals with medications for treatment of opioid use disorder: A matched cohort study from 4 US health systems, 2012–2021. Nguyen AP, et al. Journal of Substance Use and Addiction Treatment 2026 (in press). Implementing pragmatic clinical trials in rural settings: Challenges, solutions and lessons learned. Hser Y, et al. Journal of Substance Use and Addiction Treatment 2026 (in press). (CTN-0102, CTN-0102-XR) Guiding principles for clinical research on substance use in rural communities [commentary]. Bunting AM & Winstanley EL. Journal of Substance Use and Addiction Treatment 2026 (in press). Comorbidities of substance use: Opportunities realized and future needs [commentary]. Feinberg J, et al. Journal of Substance Use and Addiction…

  • Node News: Health System Node
    Node News

    News from the Health System Node

    A recent publication by Health System Node faculty, Stacy Sterling, DrPH, MSW, MPH, was selected as one of the top Quality Improvement/Implementation Science publications in the Journal of General Internal Medicine: A Randomized Trial of Alcohol Telemedicine in Primary Care: Pharmacotherapy and Referral Outcomes. J Gen Intern Med. 2026 Jan;41(1):6-15. Dr. Sterling presents this project in this JGIM webinar (if you’re not already a JGIM/SGIM member, you must register, but it’s straightforward and free). A new study led by Anh Nguyen, PhD, Health System Node faculty and Investigator at the Kaiser Permanente Colorado Institute for Health Research, published in JAMA Psychiatry showed that experiencing health plan disenrollment after initiating medications for opioid use disorder (MOUD)—such as buprenorphine or naltrexone—is a significant risk factor for elevated mortality. Losing or changing insurance coverage disrupts continuous treatment and significantly increases the likelihood of fatal overdoses and all-cause mortality. This important work was recently highlighted by Dr. Yngvild Olsen, former Director of the SAMHSA Center for Substance Abuse Treatment, in her expert testimony before the US House Energy and Commerce Committee hearing on the overdose crisis.

  • CIRCL logo
    Other

    CTN Community Representation Council Meeting Summary (April 2026)

    The Clinical Trials Network, funded by the National Institute on Drug Abuse, proudly collaborates with its Community Representative Council (CIRCL). Comprised of 16 members, one for each Node of the CTN, the CIRCL meets bi-monthly to courageously share what’s happening in their communities.  The Northeast Node is proud to serve as administrative support for this community-led initiative. Questions about CIRCL – or for CIRCL – can be directed to Bethany.M.McLeman@Dartmouth.edu.  This brief is an overview of topics discussed at this meeting and is not an exhaustive review. Download a copy of the brief. The following themes and discussions were highlighted during the April 2026 meeting: The thoughts and experiences herein are those of CIRCL members and do not represent the National Institute on Drug Abuse or the Clinical Trials Network. The voices empowered by CIRCL are intended to drive research and clinical efforts in the CTN and across the US. Trends in substance use Kratom presents new concerns Engaging law enforcement Treatment needs Spotlight on peers Taking “Meet them where they’re at” literally Research opportunities Posted on May 12, 2026

  • Southwest Node: PARTNERING WITH TRIBAL SERVING PROGRAMS TO ENHANCE CULTURE IN THE DELIVERY OF SUBSTANCE USE DISORDER TREATMENT. June 9, 11am EDT
    Node News

    News from the Southwest Node: Webinar on CTN-0096 (June 9, 11am EDT)

    The Southwest Node is hosting an upcoming webinar, featuring speakers Kamilla Venner, PhD, and Aimee Campbell, PhD, MSW, and reviewing results from CTN-0096. Partnering with Tribal Serving Programs to Enhance Culture in the Delivery of Substance Use Disorder Treatment June 9, 2026 | 11am EDT | Download flyer This project looked at adding culture to care for Alaska Native and American Indian people who had problems with opioid use. The care was medication treatment. We wanted to see if culture would help more people start and stay in treatment. We worked with four clinics. We invited Alaska Native and American Indian people to be on our Collaborative Board to help us with this project. Two American Indian women led groups at each clinic. Each clinic chose its own way to include culture in medication treatment. After culture was added, Alaska Native and American Indian customer-owners were more likely to start treatment and more likely to stay in treatment. These results suggest that including culture can help improve services for Alaska Native and American Indian people. Join the Zoom session here!Meeting ID: 977 4576 0996Passcode: SWCTN

  • Node News
    Events,  Node News

    News from the Greater Intermountain Node: Webinar: Psychedelic-Assisted Interventions for Mental Health & SUD (June 16, 12pm MST)

    Join the Greater Intermountain Node on June 16, 2026 (12-1pm MST) for their next GIN on the Rocks webinar: Psychedelic-Assisted Interventions for Mental Health and Substance Use: Current Evidence and Emerging Directions Presenter: Yitong Xin, PhD Psychedelic-assisted interventions have gained significant scientific and public attention, yet many researchers and clinicians remain unfamiliar with the current state of the evidence. This presentation will provide an accessible overview of psychedelic science and emerging clinical evidence across depression, trauma, and substance use, with Dr. Xin highlighting her research program’s contributions across multiple populationsand substances. The presentation concludes with a discussion of where the addiction research community can contribute.About the speaker:Yitong Xin, Ph.D., is an Assistant Professor at the College of Social Work, University of Utah. Her work focuses on clinical research at the intersection of mental health and substance use treatment, emphasizing harm reduction (e.g., psychedelic-assisted interventions) and strengths-based methodologies. Dr. Xin earned her Ph.D. from The Ohio State University, where she trained at theCenter for Psychedelic Drug Research and Education. Join the Zoom:Meeting ID: 835 8472 5058Passcode: ginotr

  • CTN SIG Updates
    SIG Updates

    CTN T&I SIG Survey of Implementation Research Interests and Training Needs

    Members of the CTN Translation & Implementation Special Interest Group (T&I SIG) from the Center for Dissemination & Implementation At Stanford (C-DIAS) invite you to complete a brief, online survey to understand implementation research interests and training needs in the field of addiction research.  The survey is confidential and will take about 5 minutes to complete. After completing the survey, you will have an opportunity to enter your email address on a separate form to receive an aggregate summary of survey findings.  If you would like to participate, please access the survey here. If you have any questions, please contact Dr. Mark McGovern, Professor of Psychiatry and of Medicine at Stanford University School of Medicine, at mpmcg@stanford.edu. Thank you for helping shape future implementation research training and capacity-building efforts for the field of addiction research! Posted on April 20, 2026, Updated May 5, 2026